Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib ...

Standing in its path in the early-breast cancer category is Eli Lilly’s Verzenio (abemaciclib), which was approved by the FDA for adjuvant ... to file for approval of Kisqali in the new ...

“Over our years supporting younger patients, we’ve seen far too many with HR+ breast cancer become metastatic even while on maintenance endocrine therapy,” said MJ DeCoteau, Founder and Executive ...

GSK just hit one of its main objectives for 2025 after getting FDA approval of anti-IL-5 antibody Nucala as a treatment for chronic obstructive pulmonary disease (COPD). Nucala (mepolizumab ...